InvestorsHub Logo
Followers 19
Posts 932
Boards Moderated 0
Alias Born 06/29/2020

Re: sanMillion post# 90825

Saturday, 07/04/2020 8:09:41 PM

Saturday, July 04, 2020 8:09:41 PM

Post# of 232155
Here the research for Tocilizumab:
"In conclusion, both intravenous and subcutaneous tocilizumab administration might be capable of reducing the risk of invasive mechanical ventilation or death in patients with severe COVID-19 pneumonia. Although these results are encouraging, they should be confirmed in ongoing randomised studies." https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30173-9/fulltext
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News